The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on fibrinolysis

J Thromb Haemost. 2020 Sep;18(9):2408-2411. doi: 10.1111/jth.14956.

¹ Department of Haematology, Manchester University Hospitals, Manchester, UK.
² Haemostasis Section, Biotherapeutics, National Institute for Biological Standards and Control, Potters Bar, UK.
³ Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, Westmead, NSW, Australia.
⁴ Section of Clinical Biochemistry, University of Verona, Verona, Italy.
⁵ Department of Medical Physiology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
⁶ Department of Medicine, McMaster University and Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada.

No abstract available

Keywords: COVID‐19; D‐dimer; biomarker; diagnostics; thrombosis.

Publication types